Performance of the Salt Lake Mask System
Assessment of the Performance of the Salt Lake Mask System as a Patient Interface in the Provision of Positive Airway Pressure (PAP) Therapy
1 other identifier
interventional
20
1 country
1
Brief Summary
Assessment of the performance of the Salt Lake mask system acting as a patient interface in the provision of PAP therapy. This study will assess the suitability of this mask system in its current form for use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jun 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Posted
Study publicly available on registry
July 15, 2011
CompletedApril 20, 2012
April 1, 2012
1 month
June 29, 2011
April 19, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Subjectively Assessed Levels of Seal, Comfort, Stability and Overall Performance.
Participants in the study will complete a subjective assessment of the levels of seal, comfort, stability and overall Performance of Salt Lake Mask System in use.
1 week
Secondary Outcomes (2)
Subjective Assessments of Ease and Intuitiveness in Assembly and Disassembly
1 week
Subjectively Assessed Levels of Skin Markings
1 week
Study Arms (1)
Salt Lake mask system
EXPERIMENTALInterventions
Study participants will Salt Lake mask system for 1 week in place of their current mask system.
Eligibility Criteria
You may qualify if:
- Patients willing to give written informed consent
- Patients who can read and comprehend English
- Patients using the Swift FX mask system
- Patients who can trial the mask for 7 nights
- Patients who have used PAP therapy for a minimum of 6 months.
You may not qualify if:
- Patients not willing to give written informed consent
- Patients who can not read and comprehend English
- Patients using an inappropriate mask system
- Patients using Bilevel flow generators
- Patients who are pregnant
- Patients who are unable to comply with the protocol
- Patients who have used PAP therapy for less than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ResMedlead
Study Sites (1)
ResMed Ltd
Sydney, New South Wales, 2153, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaus Schindhelm
ResMed
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2011
First Posted
July 15, 2011
Study Start
June 1, 2011
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
April 20, 2012
Record last verified: 2012-04